433 related articles for article (PubMed ID: 15825518)
1. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
Ellis JA; West KH; Waldner C; Rhodes C
Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
[TBL] [Abstract][Full Text] [Related]
3. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy of an inactivated vaccine against bovine respiratory syncytial virus in calves with maternal antibodies.
Patel JR; Didlick SA
Am J Vet Res; 2004 Apr; 65(4):417-21. PubMed ID: 15077682
[TBL] [Abstract][Full Text] [Related]
5. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
Ellis JA; Gow SP; Mahan S; Leyh R
J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
[TBL] [Abstract][Full Text] [Related]
6. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
[TBL] [Abstract][Full Text] [Related]
7. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
Ellis JA; Gow SP; Goji N
J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.
Ellis J; Gow S; Berenik A; Lacoste S; Erickson N
Can Vet J; 2018 Dec; 59(12):1311-1319. PubMed ID: 30532289
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
10. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines.
Ellis JA; Hassard LE; Morley PS
J Am Vet Med Assoc; 1995 Feb; 206(3):354-61. PubMed ID: 7751246
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.
Vangeel I; Antonis AF; Fluess M; Riegler L; Peters AR; Harmeyer SS
Vet J; 2007 Nov; 174(3):627-35. PubMed ID: 17169592
[TBL] [Abstract][Full Text] [Related]
12. Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.
Hägglund S; Hu KF; Larsen LE; Hakhverdyan M; Valarcher JF; Taylor G; Morein B; Belák S; Alenius S
Vaccine; 2004 Dec; 23(5):646-55. PubMed ID: 15542185
[TBL] [Abstract][Full Text] [Related]
13. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves.
Woolums AR; Brown CC; Brown JC; Cole DJ; Scott MA; Williams SM; Miao C
Am J Vet Res; 2004 Mar; 65(3):363-72. PubMed ID: 15027687
[TBL] [Abstract][Full Text] [Related]
14. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
Riffault S; Meyer G; Deplanche M; Dubuquoy C; Durand G; Soulestin M; Castagné N; Bernard J; Bernardet P; Dubosclard V; Bernex F; Petit-Camurdan A; Deville S; Schwartz-Cornil I; Eléouët JF
Vaccine; 2010 May; 28(21):3722-34. PubMed ID: 20307593
[TBL] [Abstract][Full Text] [Related]
15. The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves.
West K; Petrie L; Haines DM; Konoby C; Clark EG; Martin K; Ellis JA
Vaccine; 1999 Feb; 17(7-8):809-20. PubMed ID: 10067686
[TBL] [Abstract][Full Text] [Related]
16. Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination.
Larsen LE; Tegtmeier C; Pedersen E
Acta Vet Scand; 2001; 42(1):113-21. PubMed ID: 11455891
[TBL] [Abstract][Full Text] [Related]
17. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
18. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
[TBL] [Abstract][Full Text] [Related]
19. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
[TBL] [Abstract][Full Text] [Related]
20. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
